Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study-Reference-Cited by-同舟云学术

Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study

Published:2011-07-14 Issue:4 Volume:23 Page:255-260
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Vena Gino A.¹,Galluccio Antonia²,Pezza Michele²,Vestita Michelangelo¹,Cassano Nicoletta¹

Affiliation:

1. 2nd Dermatology Clinic, University of Bari, Bari, Italy

2. Dermatology Unit, Ospedale Fatebenefratelli, Benevento, Italy

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.3109/09546634.2011.565017

Reference19 articles.

1. The topical treatment of psoriasis

2. Calcipotriol/Betamethasone Dipropionate

3. Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris

4. A Two-Compound Product Containing Calcipotriol and Betamethasone Dipropionate Provides Rapid, Effective Treatment of Psoriasis vulgaris regardless of Baseline Disease Severity

5. Efficacy Results of a 52-Week, Randomised, Double-Blind, Safety Study of a Calcipotriol/Betamethasone Dipropionate Two-Compound Product (Daivobet®/Dovobet®/Taclonex®) in the Treatment of Psoriasis Vulgaris

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topical therapy for psoriasis;Journal of the Korean Society for Psoriasis;2024-06-30

2. Efficacy and safety of various drug combinations in treating plaque Psoriasis: A meta-analysis;F1000Research;2024-05-07

3. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-07-12

4. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis;Cochrane Database of Systematic Reviews;2022-05-23

5. Clinical efficacy and safety of using calcipotriol–betamethasone compounding agent for psoriasis treatment: a systematic review and meta-analysis;Archives of Dermatological Research;2021-08-20